Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.

Get the latest Tempest Therapeutics, Inc. (TPST) stock news and headlines to help you in your trading and investing decisions.

Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China Provided by GlobeNewswire Jun 30, 2025, 5:00:00 AM ...

Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest ...

Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world ...

Behind the theatrical legend was a man as complex as the characters he created -- flawed, ambitious, and unapologetically ...

Viking Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $90.69. The company has a one-year high of $81.73 and a one-year low of $18.92. Currently, Viking ...

The all-new XP Trike2 builds on the award-winning design of the most popular electric tricycle, the XP Trike, with loads of ...

THE Bard of Salford Dr John Cooper Clarke is set to return to Kidderminster for a performance at the revamped town hall which is set to reopen soon. The poet is known for fusing punk spirit with razor ...

As young adult authors are venturing into the adult market in higher numbers, we surveyed several of the biggest names to ...

Lincoln Center Theater has received a generous leadership gift from Board Chair Kewsong Lee and his wife Zita Ezpeleta to ...

The war industry cannibalises all others, and there's no shortage of hypocrisy in today's global security discourse. Powerful ...